As of June 30, 2026, Veritas In Silico Inc. carries a market capitalization of 2.80B, placing it among publicly traded companies globally. Its enterprise value stands at 1.37B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 2.80B |
| Enterprise Value | 1.37B |
Veritas In Silico Inc.'s next confirmed earnings release is scheduled for November 11, 2026.
| Earnings Date | 11/11/2026 |
As of June 30, 2026, Veritas In Silico Inc. has 6.49M shares outstanding.
| Shares Outstanding | 6.49M |
These figures are as of June 30, 2026.
| PB Ratio | 2.00 |
| P/TBV Ratio | 2.00 |
As of June 30, 2026, Veritas In Silico Inc. maintains a current ratio of 16.46, meaning it holds 16.5x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 16.46 |
| Quick Ratio | 15.72 |
These figures cover the twelve months ended June 30, 2026.
| Employee Count | 19.00 |
As of the close on October 22, 2026, Veritas In Silico Inc.'s stock has declined approximately 46.62% over the past 52 weeks. The 50-day moving average sits at 420.30, while the 200-day moving average is 446.48.
| 52-Week Price Change | -46.62% |
| 50-Day Moving Average | 420.30 |
| 200-Day Moving Average | 446.48 |
These figures are as of June 30, 2026. Total book value stands at 1.40B, with working capital of 1.41B providing operational flexibility.
| Cash & Cash Equivalents | 1.43B |
| Net Debt | -1.43B |
| Equity (Book Value) | 1.40B |
| Book Value Per Share | 215.39 |
| Working Capital | 1.41B |
Already premium?